Association	O
of	O
Exclusive	O
Breastfeeding	O
Duration	O
With	O
Systemic	O
Inflammation	O
Markers	B:C0005516
in	O
Adolescents	O
:	O
A	O
Cross-Sectional	O
Study	I:C0010362
.	O

Association	O
of	O
Exclusive	O
Breastfeeding	O
Duration	O
With	O
Systemic	O
Inflammation	O
Markers	O
in	O
Adolescents	O
:	O
A	O
Cross-Sectional	B:C0010362
Study	I:C0010362
.	O

Breastfeeding	O
duration	O
has	O
been	O
associated	O
with	O
less	O
low	O
-	O
grade	O
inflammation	B:C0021368
in	O
healthy	O
adolescents	O
,	O
but	O
there	O
is	O
scarce	O
information	O
regarding	O
obese	O
subjects	O
.	O

Breastfeeding	O
duration	O
has	O
been	O
associated	O
with	O
less	O
low	O
-	O
grade	O
inflammation	O
in	O
healthy	O
adolescents	O
,	O
but	O
there	O
is	O
scarce	O
information	O
regarding	O
obese	B:C0028754
subjects	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
whether	O
exclusive	O
breastfeeding	O
is	O
related	O
to	O
serum	O
concentrations	O
of	O
inflammatory	O
markers	B:C0005516
in	O
a	O
population	O
of	O
Spanish	O
adolescents	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
whether	O
exclusive	O
breastfeeding	O
is	O
related	O
to	O
serum	O
concentrations	O
of	O
inflammatory	O
markers	O
in	O
a	O
population	B:C1257890
of	O
Spanish	O
adolescents	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
whether	O
exclusive	O
breastfeeding	O
is	O
related	O
to	O
serum	O
concentrations	O
of	O
inflammatory	O
markers	O
in	O
a	O
population	O
of	O
Spanish	B:C0086409
adolescents	O
.	O

A	O
cross-sectional	B:C0010362
study	I:C0010362
was	O
performed	O
on	O
1,001	O
adolescents	O
(	O
13.2	O
±	O
1.2	O
years	O
)	O
randomly	O
recruited	O
from	O
schools	O
in	O
southeast	O
Spain	O
.	O

A	O
cross-sectional	O
study	I:C0010362
was	O
performed	O
on	O
1,001	O
adolescents	O
(	O
13.2	O
±	O
1.2	O
years	O
)	O
randomly	O
recruited	O
from	O
schools	B:C0036375
in	O
southeast	O
Spain	O
.	O

A	O
cross-sectional	O
study	I:C0010362
was	O
performed	O
on	O
1,001	O
adolescents	O
(	O
13.2	O
±	O
1.2	O
years	O
)	O
randomly	O
recruited	O
from	O
schools	O
in	O
southeast	B:C1711190
Spain	O
.	O

A	O
cross-sectional	O
study	I:C0010362
was	O
performed	O
on	O
1,001	O
adolescents	O
(	O
13.2	O
±	O
1.2	O
years	O
)	O
randomly	O
recruited	O
from	O
schools	O
in	O
southeast	O
Spain	B:C0037747
.	O

Data	O
on	O
breastfeeding	O
duration	O
were	O
collected	O
via	O
a	O
parental	B:C0034394
questionnaire	I:C0034394
.	O

Interleukin	B:C0021760
-6	I:C0021760
(	O
Interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
)	O
were	O
determined	O
by	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

Interleukin	O
-6	I:C0021760
(	O
Interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
)	O
were	O
determined	O
by	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

Interleukin	O
-6	I:C0021760
(	O
Interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
)	O
were	O
determined	O
by	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

Interleukin	O
-6	I:C0021760
(	O
Interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
(	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
)	O
were	O
determined	O
by	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

Interleukin	O
-6	I:C0021760
(	O
Interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
)	O
were	O
determined	O
by	O
enzyme	B:C0014441
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

C-reactive	B:C0006560
protein	I:C0006560
(	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
)	O
was	O
determined	O
by	O
solid	O
-	I:C0020980
phase	I:C0020980
chemiluminescent	I:C0020980
immunometric	I:C0020980
assay	I:C0020980
.	O

C-reactive	O
protein	I:C0006560
(	O
C	B:C0006560
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
)	O
was	O
determined	O
by	O
solid	O
-	I:C0020980
phase	I:C0020980
chemiluminescent	I:C0020980
immunometric	I:C0020980
assay	I:C0020980
.	O

C-reactive	O
protein	I:C0006560
(	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
)	O
was	O
determined	O
by	O
solid	B:C0020980
-	I:C0020980
phase	I:C0020980
chemiluminescent	I:C0020980
immunometric	I:C0020980
assay	I:C0020980
.	O

Nonadjusted	O
and	O
adjusted	O
multivariate	O
correlation	B:C0010101
analyses	I:C0010101
confirmed	O
a	O
strong	O
association	O
(	O
p	O
<	O
.001	O
,	O
95	O
%	O
confidence	O
interval	O
)	O
between	O
the	O
three	O
markers	O
of	O
inflammation	O
and	O
exclusive	O
breastfeeding	O
duration	O
.	O

Nonadjusted	O
and	O
adjusted	O
multivariate	O
correlation	O
analyses	I:C0010101
confirmed	O
a	O
strong	O
association	O
(	O
p	O
<	O
.001	O
,	O
95	O
%	O
confidence	O
interval	O
)	O
between	O
the	O
three	O
markers	B:C0005516
of	O
inflammation	O
and	O
exclusive	O
breastfeeding	O
duration	O
.	O

Nonadjusted	O
and	O
adjusted	O
multivariate	O
correlation	O
analyses	I:C0010101
confirmed	O
a	O
strong	O
association	O
(	O
p	O
<	O
.001	O
,	O
95	O
%	O
confidence	O
interval	O
)	O
between	O
the	O
three	O
markers	O
of	O
inflammation	B:C0021368
and	O
exclusive	O
breastfeeding	O
duration	O
.	O

No	B:C1273937
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	B:C0006560
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	B:C1285592
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	B:C0497406
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	B:C0028754
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	B:C1285592
weight	I:C1285592
and	O
obese	O
subjects	O
.	O

No	O
significant	I:C1273937
differences	O
were	O
observed	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
,	O
and	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
serum	O
concentrations	O
among	O
normal	O
weight	I:C1285592
,	O
overweight	O
,	O
and	O
obese	O
adolescents	O
,	O
except	O
for	O
Interleukin	O
-	I:C0021760
6	I:C0021760
between	O
normal	O
weight	I:C1285592
and	O
obese	B:C0028754
subjects	O
.	O

Likewise	O
,	O
no	B:C1273937
significant	I:C1273937
association	O
was	O
found	O
between	O
these	O
markers	O
of	O
inflammation	O
and	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
z	O
-	O
score	O
.	O

Likewise	O
,	O
no	O
significant	I:C1273937
association	O
was	O
found	B:C0150312
between	O
these	O
markers	O
of	O
inflammation	O
and	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
z	O
-	O
score	O
.	O

Likewise	O
,	O
no	O
significant	I:C1273937
association	O
was	O
found	O
between	O
these	O
markers	B:C0005516
of	O
inflammation	O
and	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
z	O
-	O
score	O
.	O

Likewise	O
,	O
no	O
significant	I:C1273937
association	O
was	O
found	O
between	O
these	O
markers	O
of	O
inflammation	B:C0021368
and	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
z	O
-	O
score	O
.	O

Likewise	O
,	O
no	O
significant	I:C1273937
association	O
was	O
found	O
between	O
these	O
markers	O
of	O
inflammation	O
and	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
z	O
-	O
score	O
.	O

Likewise	O
,	O
no	O
significant	I:C1273937
association	O
was	O
found	O
between	O
these	O
markers	O
of	O
inflammation	O
and	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
)	O
z	O
-	O
score	O
.	O

We	O
found	B:C0150312
a	O
possible	O
association	O
between	O
inflammatory	O
markers	O
and	O
exclusive	O
breastfeeding	O
duration	O
in	O
adolescents	O
,	O
regardless	O
of	O
their	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

We	O
found	O
a	O
possible	B:C0332149
association	O
between	O
inflammatory	O
markers	O
and	O
exclusive	O
breastfeeding	O
duration	O
in	O
adolescents	O
,	O
regardless	O
of	O
their	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

We	O
found	O
a	O
possible	O
association	O
between	O
inflammatory	O
markers	B:C0005516
and	O
exclusive	O
breastfeeding	O
duration	O
in	O
adolescents	O
,	O
regardless	O
of	O
their	O
body	O
mass	I:C1305855
index	I:C1305855
.	O

We	O
found	O
a	O
possible	O
association	O
between	O
inflammatory	O
markers	O
and	O
exclusive	O
breastfeeding	O
duration	O
in	O
adolescents	O
,	O
regardless	O
of	O
their	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
.	O

This	O
finding	B:C0243095
suggests	O
that	O
increased	O
body	O
weight	O
or	O
obesity	O
might	O
not	O
mediate	O
the	O
association	O
between	O
breastfeeding	O
and	O
inflammation	O
.	O

This	O
finding	O
suggests	O
that	O
increased	O
body	O
weight	O
or	O
obesity	B:C0028754
might	O
not	O
mediate	O
the	O
association	O
between	O
breastfeeding	O
and	O
inflammation	O
.	O

This	O
finding	O
suggests	O
that	O
increased	O
body	O
weight	O
or	O
obesity	O
might	O
not	O
mediate	O
the	O
association	O
between	O
breastfeeding	B:C0006147
and	O
inflammation	O
.	O

This	O
finding	O
suggests	O
that	O
increased	O
body	O
weight	O
or	O
obesity	O
might	O
not	O
mediate	O
the	O
association	O
between	O
breastfeeding	O
and	O
inflammation	B:C0021368
.	O

These	O
results	O
contribute	O
to	O
the	O
understanding	B:C0162340
of	O
the	O
relationship	O
between	O
breastfeeding	O
and	O
inflammatory	O
markers	O
in	O
adolescents	O
.	O

These	O
results	O
contribute	O
to	O
the	O
understanding	O
of	O
the	O
relationship	O
between	O
breastfeeding	B:C0006147
and	O
inflammatory	O
markers	O
in	O
adolescents	O
.	O

These	O
results	O
contribute	O
to	O
the	O
understanding	O
of	O
the	O
relationship	O
between	O
breastfeeding	O
and	O
inflammatory	O
markers	B:C0005516
in	O
adolescents	O
.	O

